Regulatory remediation SSI specializes in methodology, process and project management for compliance remediation in pharmaceutical, biotechnology and medical device industries, presenting a clear opportunity to cross-sell PMO and remediation services to firms facing consent decrees, warning letters, and 483 issues.

Global reform programs Their experience delivering remediation management programs across multi-site and global operations suggests potential value in helping large manufacturers standardize quality initiatives, accelerate global launches and manage facility licensure and commissioning projects.

Strategic partnerships Misonix acquisition and board involvement indicate SSI’s fit within broader medical device and surgical platforms, presenting a path to SAP-like integration services, program governance, and ongoing quality improvement initiatives for connected device ecosystems.

Limited but nimble With a small team, SSI can offer highly tailored, fast-moving engagements ideal for mid-market pharma/biotech players seeking expert PMO setup, compliance remediation frameworks, and scalable project management without large vendor overhead.

Tech-enabled delivery Utilizing tools like Google Workplace, Cloud, Sentry, and React indicates readiness for modern, collaborative delivery models; this can be highlighted to prospective clients as scalable, transparent project tracking and robust risk management capabilities.